FORZ — Forza Innovations Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.25m
- $2.31m
- $0.11m
Annual income statement for Forza Innovations, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.769 | 0.605 | 0 | 0.026 | 0.115 |
| Cost of Revenue | |||||
| Gross Profit | 0.311 | 0.207 | — | 0.023 | 0.088 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.606 | 0.63 | 2.77 | 2 | 1.27 |
| Operating Profit | 0.162 | -0.025 | -2.77 | -1.97 | -1.15 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.141 | -0.321 | -3.17 | -2.7 | -4.76 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.103 | -0.321 | -3.17 | -2.7 | -4.76 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 0.103 | -0.321 | -3.14 | -2.7 | -4.76 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.103 | -0.321 | -3.14 | -2.7 | -4.76 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0 | -0.002 | -0 | -0.009 | -0.006 |